Sumitomo Mitsui Trust Holdings, Inc. Astrazeneca PLC Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $134 Billion
- Q2 2024
A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 74,716 shares of AZN stock, worth $5.86 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
74,716
Previous 78,873
5.27%
Holding current value
$5.86 Million
Previous $5.34 Million
9.06%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding AZN
# of Institutions
1,332Shares Held
490MCall Options Held
4.99MPut Options Held
3.19M-
Price T Rowe Associates Inc Baltimore, MD64.9MShares$5.09 Billion0.61% of portfolio
-
Primecap Management CO Pasadena, CA42.6MShares$3.34 Billion2.44% of portfolio
-
Wellington Management Group LLP Boston, MA40.6MShares$3.18 Billion0.58% of portfolio
-
Capital International Investors Los Angeles, CA36.7MShares$2.88 Billion0.6% of portfolio
-
Franklin Resources Inc San Mateo, CA17.6MShares$1.38 Billion0.44% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $243B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...